Effect of rituximab dose on induction therapy in ABO-incompatible living kidney transplantation: A network meta-analysis

BACKGROUND: Rituximab is an induction immunosuppressant essential for ABO-incompatible kidney transplantation (ABOi KT). However, studies on its dosing, which differs among countries and transplant centers, are lacking. Therefore, we retrospectively investigated the effectiveness of the induction do...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Hee Ryong, Kim, Kipyo, Lee, Seoung Woo, Song, Joon Ho, Lee, Jin Ho, Hwang, Seun Deuk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
5200
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7969271/
https://www.ncbi.nlm.nih.gov/pubmed/33725841
http://dx.doi.org/10.1097/MD.0000000000024853

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7969271/
https://www.ncbi.nlm.nih.gov/pubmed/33725841
http://dx.doi.org/10.1097/MD.0000000000024853

Ejemplares similares